TITLE

Germany : Bayer continues positive business development

PUB. DATE
July 2014
SOURCE
TendersInfo News;7/31/2014, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that pharmaceutical company Bayer Group has reported the rise in revenue and profit as of second quarter of 2014 and considered as a good business development. It mentions that EBITDA before special items and core earnings per share also showed improvement and the planned acquisition of the consumer care activities of U.S. company Merck. It presents the views of Marijn Dekkers, Management Board Chairman, of Bayer, on the same.
ACCESSION #
116733646

 

Related Articles

  • Health Management Announces 2nd Quarter 2012 Results.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article presents information about the financial statement of Health Management Associates Inc. for its second quarter and six months ending June 30, 2012. It reported its business revenue of about 20.2 percent and diluted earnings per share from operations to 0.21 percent as compared to the...

  • Germany : BMW Group success continues in second quarter.  // TendersInfo News;8/6/2014, p1 

    The article reports on the financial performance of Bayerische Motoren Werke AG (BMW Group) for the first half of 2014. The German automotive manufacturer has increased its sales volume, revenues and Group earnings in the second quarter. BMW Group has raised its earnings before interest and tax...

  • BAYER AG.  // MondayMorning;4/29/2013, Vol. 21 Issue 16, p1 

    The article reports on financial performance of the German chemical and pharmaceutical company Bayer AG for the first quarter of 2013. It mentions that the company's earnings before interest, taxes and special items have increased by 0.4 percent. It further informs about the future plans of the...

  • European IP group Murgitroyd's profit drops by 11 per cent as US client base grows. Stanton, Natalie // Lawyer (Online Edition);9/8/2014, p4 

    The article reports on the financial performance of patent and trademark law firm Murgitroyd from 2013-2014. Among the key indicators of the firm's financial performance include the earnings per share (EPS), corporate profit, and generated revenue. Other topics include the firm's plan to invest...

  • Foot Locker: Set For A Rebound? MATTHEW GALGANI // Investors Business Daily;10/20/2014, pB10 

    The article reports on the growth of athletic footwear company Foot Locker. Topics discussed include the potential holiday sales growth of the retailer, the revenue, earnings, and profit gains of the company in the third quarter (Q3) of 2014, and the earnings per share (EPS) forecast by 2016....

  • Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010.  // Chemical Business;Oct2009, Vol. 23 Issue 10, p72 

    The article announces the appointment of Dr. Marijn E. Dekkers as chief executive officer (CEO) of Bayer AG effective October 1, 2010.

  • Find And Use The EPS Rating; It Fast-Tracks Basic Research. ALAN R. ELLIOTT // Investors Business Daily;6/23/2014, pB07 

    Few concepts receive as much airplay in the investment trade as EPS, an acronym for "earnings per share."

  • Finland : UPM posts strong second quarter, solid progress in growth projects.  // TendersInfo News;8/6/2014, p1 

    The article reports on the financial performance of Finnish forest industry company UPM-Kymmene Oyj for the second quarter of 2014. The company has posted an increase in earnings per share and EBITDA. Operating profit excluding special items has significantly raised, due to the successful profit...

  • Anglo American announces underlying EBITDA of US$ 8.7 billion, profit decrease to US$ 6.2 billion.  // African Business News;2/19/2013, p3 

    The article offers information on the financial performance of platinum producer Anglo American Platinum Ltd. in South Africa in 2013. The company announces $8.7 billion underlying EBITDA and a decline in underlying operating profit to $6.2 billion. The underlying earnings per share (EPS) of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics